최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기Journal of microbiology and biotechnology, v.26 no.3, 2016년, pp.572 - 578
Wang, Wenshuo (Department of Cardiac Surgery, Zhongshan Hospital of Fudan University and Shanghai Institute of Cardiovascular Diseases) , Yang, Ye (Department of Cardiac Surgery, Zhongshan Hospital of Fudan University and Shanghai Institute of Cardiovascular Diseases) , Wang, Yiqing (Department of Cardiothoracic Surgery, Huashan Hospital of Fudan University) , Pang, Liewen (Department of Cardiothoracic Surgery, Huashan Hospital of Fudan University) , Huang, Jiechun (Department of Cardiothoracic Surgery, Huashan Hospital of Fudan University) , Tao, Hongyue (Department of Radiology, Huashan Hospital of Fudan University) , Sun, Xiaotian (Department of Cardiothoracic Surgery, Huashan Hospital of Fudan University) , Liu, Chen (Department of Cardiac Surgery, Zhongshan Hospital of Fudan University and Shanghai Institute of Cardiovascular Diseases)
Communication between endothelial cells (ECs) and smooth muscle cells (SMCs) via miR-143/145 clusters is vital to vascular stability. Previous research demonstrates that miR-143/145 released from ECs can regulate SMC proliferation and migration. In addition, a recent study has found that SMCs also h...
Abramsson A, Lindblom P, Betsholtz C. 2003. Endothelial and nonendothelial sources of PDGF-B regulate pericyte recruitment and influence vascular pattern formation in tumors. J. Clin. Invest. 112: 1142-1151.
Akao Y, Nakagawa Y, Kitade Y, Kinoshita T, Naoe T. 2007. Downregulation of microRNAs-143 and -145 in B-cell malignancies. Cancer Sci. 98: 1914-1920.
Bartel DP. 2004. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297.
Benjamin LE, Hemo I, Keshet E. 1998. A plasticity window for blood vessel remodelling is defined by pericyte coverage of the preformed endothelial network and is regulated by PDGF-B and VEGF. Development 125: 1591-1598.
Benton HP, Ivanisevic J, Mahieu NG, Kurczy ME, Johnson CH, Franco L, et al. 2014. Autonomous metabolomics for rapid metabolite identification in global profiling. Anal. Chem. 87: 884-891.
Bonetti PO, Lerman LO, Lerman A. 2003. Endothelial dysfunction: a marker of atherosclerotic risk. Arterioscler. Thromb. Vasc. Biol. 23: 168-175.
Climent M, Quintavalle M, Miragoli M, Chen J, Condorelli G, Elia L. 2015. TGFβ triggers miR-143/145 transfer from smooth muscle cells to endothelial cells, thereby modulating vessel stabilization. Circ. Res. 116: 1753-1764.
Condorelli G, Latronico MV, Cavarretta E. 2014. MicroRNAs in cardiovascular diseases: current knowledge and the road ahead. J. Am. Coll. Cardiol. 63: 2177-2187.
Cordes KR, Sheehy NT, White MP, Berry EC, Morton SU, Muth AN, et al. 2009. miR-145 and miR-143 regulate smooth muscle cell fate and plasticity. Nature 460: 705-710.
Du Z, Zhou Y, Lu X, Li L, Lu C, Li L, et al. 2016. Octreotide prevents liver failure through upregulating 5’-methylthioadenosine in extended hepatectomized rats. Liver Int. 36: 212-222.
Ebos JM, Lee CR, Cruz-Munoz W, Bjarnason GA, Christensen JG, Kerbel RS. 2009. Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesis. Cancer Cell 15: 232-239.
Elia L, Quintavalle M, Zhang J, Contu R, Cossu L, Latronico MV, et al. 2009. The knockout of miR-143 and -145 alters smooth muscle cell maintenance and vascular homeostasis in mice: correlates with human disease. Cell Death Differ. 16: 1590-1598.
Goel S, Duda DG, Xu L, Munn LL, Boucher Y, Fukumura D, Jain RK. 2011. Normalization of the vasculature for treatment of cancer and other diseases. Physiol. Rev. 91: 1071-1121.
Hergenreider E, Heydt S, Tréguer K, Boettger T, Horrevoets AJ, Zeiher AM, et al. 2002. Atheroprotective communication between endothelial cells and smooth muscle cells through miRNAs. Nat. Cell Biol. 14: 249-256.
Iorio MV, Ferracin M, Liu CG. 2005. MicroRNA gene expression de-regulation in human breast cancer. Cancer Res. 65: 7065-7070.
Jain RK. 2003. Molecular regulation of vessel maturation. Nat. Med. 9: 685-693.
Monjazeb AM, High KP, Connoy A. 2006. Arachidonic acid-induced gene expression in colon cancer cells. Carcinogenesis 27: 1950-1960.
Pelicano H, Martin DS, Xu RH. 2006. Glycolysis inhibition for anticancer treatment. Oncogene 25: 4633-4646.
Ross R. 1999. Atherosclerosis — an inflammatory disease. N. Engl. J. Med. 340: 115-126.
Sahin M, Sahin E, Gumuslu S, Erdogan A, Gultekin M. 2010. DNA methylation or histone modification status in metastasis and angiogenesis-related genes: a new hypothesis on usage of DNMT inhibitors and S-adenosylmethionine for genome stability. Cancer Metastasis Rev. 29: 655-676.
Shiva Shankar TV, Willems L. 2014. Epigenetic modulators mitigate angiogenesis through a complex transcriptomic network. Vascul. Pharmacol. 60: 57-66.
Sonnen JA, Gray S, Larson EB, Montine TJ. 2008. Oxidative damage to human cortex in aging an antioxidant use. FASEB J. 22:167-162.
Sreekumar A, Poisson LM, Rajendiran TM. 2009. Metabolome profiles delineate potential role for sarcosine in prostate cancer progression. Nature 457: 910-914.
Turpeinen A, Basu S, Mutanen M. 1998. A high linoleic acid diet increases oxidative stress in vivo and affects nitric oxide metabolism in humans. Prostaglandins Leukot. Essent. Fatty Acids 59: 229-233.
Vander Heiden MG, Cantley LC, Thompson CB. 2009. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324: 1029-1033.
Velazquez OC. 2007. Angiogenesis and vasculogenesis: inducing the growth of new blood vessels and wound healing by stimulation of bone marrow-derived progenitor cell mobilization and homing. J. Vasc. Surg. 45: 39-47.
해당 논문의 주제분야에서 활용도가 높은 상위 5개 콘텐츠를 보여줍니다.
더보기 버튼을 클릭하시면 더 많은 관련자료를 살펴볼 수 있습니다.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.